Pancreatitis Subtypes Survey in 852 Childhood-Onset Systemic Lupus Erythematosus Patients

Carregando...
Imagem de Miniatura
Citações na Scopus
24
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
TERRERI, Maria T.
MAGALHAES, Claudia S.
GUARIENTO, Andressa
APPENZELLER, Simone
FERRIANI, Virginia P.
Citação
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, v.62, n.2, p.328-334, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective:Pancreatitis is a rare and a life-threatening systemic lupus erythematosus (SLE) manifestation in childhood-onset SLE (cSLE). The objective of this study was to systematically classify pancreatitis in cSLE according to the International Study Group of Pediatric Pancreatitis and determine the overall prevalence, clinical features, laboratory, and first episode outcomes.Methods:A multicenter cohort study in 10 pediatric rheumatology centers, including 852 patients with cSLE.Results:Pancreatitis was diagnosed in 22 of 852 (2.6%) patients with cSLE. It was classified as acute pancreatitis in 20 (91%), acute recurrent pancreatitis in 2 (9%), and none of them had chronic pancreatitis. None of them had gallstones, traumatic pancreatitis, or reported alcohol/tobacco use. The comparison of patients with pancreatitis (first episode) and without this complication revealed a shorter disease duration (1 [0-10] vs 4 [0-23] years, P<0.0001) and higher median of Systemic Lupus Erythematosus Disease Activity Index 2000 (21 [0-41] vs 2 [0-45], P<0.0001). The frequencies of fever (P<0.0001), weight loss (P<0.0001), serositis (P<0.0001), nephritis (P<0.0001), arterial hypertension (P<0.0001), acute renal failure (P<0.0001), macrophage activation syndrome (P<0.0001), and death (P=0.001) were also higher in patients with pancreatitis. The frequencies of intravenous methylprednisolone use (P<0.0001) and the median of prednisone dose (55 [15-60] vs 11 [1-90] mg/day, P<0.0001) were significantly higher in patients with pancreatitis. Of note, the 2 patients with acute recurrent pancreatitis had 2 episodes, with pain-free interval of 1 and 4 years.Conclusions:This was the first study characterizing pancreatitis using the International Study Group of Pediatric Pancreatitis standardized definitions in patients with cSLE showing that the predominant form is acute pancreatitis seen in association with glucocorticoid treatment and active severe disease.
Palavras-chave
childhood-onset systemic lupus erythematosus, glucocorticoid, pancreatitis, Systemic Lupus Erythematosus Disease Activity Index
Referências
  1. American College of Rheumatology Ad Hoc committee of Neuro-psychiatric Lupus Syndromes. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, 1999, ARTHRITIS RHEUM, V42, P599
  2. Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779
  3. Wang CH, 2011, LUPUS, V20, P443, DOI 10.1177/0961203310387179
  4. Nesher G, 2006, SEMIN ARTHRITIS RHEU, V35, P260, DOI 10.1016/j.semarthrit.2005.08.003
  5. Campos LMA, 2010, LUPUS, V19, P1654, DOI 10.1177/0961203310378863
  6. Breuer GS, 2006, AUTOIMMUN REV, V5, P314, DOI 10.1016/j.autrev.2005.11.004
  7. Silva CA, 2012, ARTHRIT CARE RES, V64, P1787, DOI 10.1002/acr.21757
  8. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  9. Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303
  10. Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231
  11. Lautz TB, 2012, J PEDIATR SURG, V47, P1185, DOI 10.1016/j.jpedsurg.2012.03.023
  12. Morinville VD, 2012, J PEDIATR GASTR NUTR, V55, P261, DOI 10.1097/MPG.0b013e31824f1516
  13. Coffey MJ, 2013, J PEDIATR GASTR NUTR, V56, P602, DOI 10.1097/MPG.0b013e31828b36d8
  14. Pascual-Ramos V, 2004, J RHEUMATOL, V31, P707
  15. Derk CT, 2004, CLIN RHEUMATOL, V23, P147, DOI 10.1007/s10067-003-0793-3
  16. Frank B, 1999, AM J GASTROENTEROL, V94, P463
  17. Limwattana S, 2013, CLIN RHEUMATOL, V32, P913, DOI 10.1007/s10067-013-2242-2
  18. Lankisch PG, 1999, GUT, V44, P542
  19. Abu-El-Haija M, 2014, J PEDIATR GASTR NUTR, V58, P689, DOI 10.1097/MPG.0000000000000360
  20. BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  21. Avcin T, 2009, LUPUS, V18, P894, DOI 10.1177/0961203309106917
  22. Perrin L, 2006, ACTA PAEDIATR, V95, P121, DOI 10.1080/08035250500325090
  23. Tarr T, 2015, LUPUS, V24, P796, DOI 10.1177/0961203314563817
  24. Faco MMM, 2007, BRAZ J MED BIOL RES, V40, P993, DOI 10.1590/S0100-879X2006005000110
  25. Richer O, 2007, ANN RHEUM DIS, V66, P174, DOI 10.1136/ard.2005.050070
  26. Gladman DD, 2002, J RHEUMATOL, V29, P288
  27. Azevedo AB, 2003, REV BRAS REUMATOL, V43, P194
  28. Chan James C M, 2002, Pediatr Rev, V23, P47, DOI 10.1542/pir.23-2-47
  29. Mina R, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4256
  30. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, 2004, PEDIATRICS, V114, P555, DOI 10.1542/PEDS.114.2
  31. National KF, 2002, AM J KIDNEY DIS S, V39, pS1, DOI 10.1053/AJKD.2002.30582.PUBMED:11904577